I n this issue of CUAJ, readers will encounter two well-written and practical guidelines that will undoubtedly inform and support most of our daily practices. Specifically, the "CUA Guidelines on antibiotic prophylaxis for urologic procedures" 1 is an excellent addition to a highly visible and evolving area of concern of peri-procedure infections in urological care, highlighted by a growing apprehension of our typically empiric choices in a world of multi-drug resistant organisms. 2 These CUA guidelines focus on the role of antibiotic use to reduce urinary tract infections in less invasive procedures, as compared to surgical site infections after open surgeries. They strike a good balance of informing our practical needs to manage our manipulations of the urinary tract, often in the clinical context where there is at least a decent chance of colonization by uropathogens, with an eye on antibiotic stewardship that has been advocated by many other authorities and associations, including recent contributions of the AUA and Choosing Wisely.Such guidelines synthesize the available literature and provide rationale evidencebased recommendations -putting us all on the same page and, if effectively disseminated and implemented, facilitating risk reduction for our patients. Taking the recommendations for TRUSP biopsy prophylaxis as an example, how exactly should the practicing clinician interpret the document? To start with, a single dose (or very short course) of a fluoroquinolone given to a low-risk patient with a sterile urine culture remains reasonable for most communities. However, if fluoroquinolone-resistance in extended-spectrum beta-lactamase producing organisms is becoming prevalent in your local area, then a change of antimicrobial coverage to these organisms may be critical. Even better would be to base the local prophylaxis strategy on pre-biopsy rectal cultures.What becomes apparent reading the document is what these guidelines do not represent: a cookbook to be used in every clinical situation. Unfortunately these guidelines on antimicrobial prophylaxis do not (and probably should not) advise us on the specific antibiotic to employ for each procedure or the specific duration of time that is optimal to avoid significant infectious complications. At least in part, the reason for the lack of any prescriptive recommendations is due to a lack of well-controlled, contemporary trials powered sufficiently to inform us on the more important infectious outcomes of our procedures. Of the randomized trials included in the systematic review informing us on antibiotic use for TRUSP biopsy, only a few were performed in the last decade and most with primary outcomes focused only on bacteriuria. Similarly, our new guidelines are unable to define the optimal duration of prophylaxis for most of these procedures and can only refer to previous recommendations advocating shorter (<24 hours) duration despite the fact that these are based on surgical site infections in non-urological surgeries.Furthermore, the reality is that any ...